American International Group, Inc. Zynerba Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$3.31 - $6.54 $44,840 - $88,597	-13,547 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$2.9 - $6.16 $2,273 - $4,829	-784 Reduced 5.47%	13,547 $52,000
Q4 2019 Feb 05, 2020	SELL	$5.61 - $8.57 $673 - $1,028	-120 Reduced 0.83%	14,331 $87,000
Q3 2019 Nov 08, 2019	BUY	$7.56 - $15.44 $9,306 - $19,006	1,231 Added 9.31%	14,451 $109,000
Q2 2019 Aug 13, 2019	BUY	$5.4 - $15.5 $71,388 - $204,910	13,220 New	13,220 $179,000
Q2 2018 Aug 08, 2018	SELL	$7.98 - $12.39 $59,506 - $92,392	-7,457 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$8.49 - $13.46 $3,396 - $5,384	-400 Reduced 5.09%	7,457 $65,000
Q4 2017 Feb 09, 2018	BUY	$8.69 - $14.59 $1,850 - $3,107	213 Added 2.79%	7,857 $98,000
Q3 2017 Nov 09, 2017	BUY	$5.73 - $9.44 $43,800 - $72,159	7,644	7,644 $64,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.